louisiana glp-1 gastric stasis attorney Wegovy Lawsuit Over Gastroparesis Lawsuit Filed Against Ozempic, Mounjaro

Lipid levels and blood pressure showed only small changes, reflecting modest cardiometabolic effects outside glucose and weight control.

NYT's opinion page: science can't keep pace with how people are actually using these drugs

How the Program Works

Studies have shown that anywhere from 15 to 60 percent of the weight people lose on GLP-1's is lean muscle.

The two incretin peptides that enable this effect are the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide 1 (GLP-1), which ...

#ObesityMedicine #MetabolicHealth #GLP1 #ClinicalTrials #HealthcareInnovation #Semaglutide #Orforglipron #CagriSema #Retatrutide #Wegovy | 33 comments on LinkedIn